Hubei Goto Biopharm Co.,Ltd. Price (300966.SZ)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

115,025,074

(0.2185)%

Income Statement Summary

Revenue
Cost of Revenue
Gross Profit
Operating Expenses
Operating Income
Other Expenses
Net Income
news-img
Hubei Goto Biopharm Co.,Ltd.
news-img

Income Statement

Hubei Goto Biopharm Co.,Ltd.

Currency: CNY

YEAR 2017 2018 2019 2020 2021 2022 2023
Revenue
Revenue 333,692,153.00

+0%

437,301,668.00

+31%

464,801,920.00

+6%

468,117,263.00

+1%

590,885,338.00

+26%

604,571,473.00

+2%

566,399,208.00

-6%

Cost of Revenue
Cost of Revenue 231,702,304.00 306,326,509.00 333,113,561.00 361,493,701.00 434,974,623.00 466,351,809.00 450,290,741.00
Gross Profit
Gross Profit 101,989,849.00

+0%

130,975,159.00

+28%

131,688,359.00

+1%

106,623,562.00

-19%

155,910,715.00

+46%

138,219,664.00

-11%

116,108,467.00

-16%

Gross Profit Ratio (0.31%) (0.30%) (0.28%) (0.23%) (0.26%) (0.23%) (0.20%)
Operating Expenses
Research and Development 23,464,354.00 27,104,142.00 26,055,661.00 21,604,139.00 37,123,309.00 45,147,487.00 38,098,898.00
General and Administrative -14,628,865.51 -29,604,765.21 -40,601,992.46 -6,118,271.61 18,529,786.00 15,075,289.00 16,760,280.00
Selling, General & Admin... -11,288,281.56 -25,331,485.62 -36,135,153.43 -2,664,178.27 24,000,705.00 19,982,303.00 54,605,926.00
Selling & Marketing Exp... 3,340,583.00 4,273,279.00 4,466,839.00 3,454,093.00 5,470,919.00 4,907,013.00 4,177,016.00
Depreciation and Amortiz... 9,617,500.00 15,146,800.00 17,034,025.00 21,182,530.00 23,357,881.00 30,060,313.00 28,207,079.00
Other Expenses 19,092,910.00 31,960,651.00 36,657,957.00 10,064,591.00 23,405,315.00 -389,832.15 3,873,688.00
Total Operating Expenses 39,988,109.00 44,293,185.00 38,842,546.00 40,704,664.00 83,473,445.00 85,289,675.00 96,578,512.00
Cost and Exponses 271,690,414.00 350,619,695.00 371,956,108.00 402,198,366.00 518,448,068.00 551,641,485.00 546,869,253.00
Operating Income
Operating Income 55,209,492.00

+0%

78,332,937.00

+42%

79,694,634.00

+2%

57,300,022.00

-28%

62,711,930.00

+9%

38,903,531.00

-38%

19,529,955.00

-50%

Operating Income Ratio (0.17%) (0.18%) (0.17%) (0.12%) (0.11%) (0.06%) (0.03%)
Other Income and Exp...
Interest Income 1,966,162.00 3,132,699.00 2,261,309.00 1,276,616.00 1,190,256.00 1,923,107.00 2,132,579.00
Interest Expenses 19,257,307.00 23,972,910.00 23,344,861.00 13,501,455.00 5,174,333.00 13,372,459.00 13,552,176.00
Total Other Income/Exp... 432,184.00 2,053,311.00 3,116,604.00 2,942,271.00 23,405,322.00 -389,832.00 -413,682.00
EBITDA
EBITDA 69,110,657.00 100,327,676.00 104,766,849.00 88,175,552.00 116,390,208.00 79,117,085.00 60,505,063.00
EBITDA ratio (0.26%) (0.28%) (0.28%) (0.21%) (0.20%) (0.14%) (0.11%)
Income Before Tax
Income Before Tax 55,641,676.00 80,386,248.00 82,811,238.00 60,242,293.00 86,117,245.00 38,513,699.00 19,116,273.00
Income Before Tax Ratio (0.17%) (0.18%) (0.18%) (0.13%) (0.15%) (0.06%) (0.03%)
Income Tax Expense
Income Tax Expense 8,202,996.00 9,708,372.00 9,814,879.00 7,046,808.00 8,051,371.00 -982,330.79 -2,173,593.00
Net Income
Net Income 47,438,680.00

+0%

70,677,875.00

+49%

72,996,358.00

+3%

53,288,521.00

-27%

78,330,635.00

+47%

40,205,160.00

-49%

23,005,014.00

-43%

Net Income Ratio (0.14%) (0.16%) (0.16%) (0.11%) (0.13%) (0.07%) (0.04%)
Earning Per Share
Basic EPS 1.03 0.84 0.63 0.46 0.68 0.35 0.20
Diluted EPS 1.03 0.84 0.63 0.46 0.68 0.35 0.20
Share Outstanding
Basic Share Outstanding 46,056,971.00 84,140,328.00 115,277,000.00 115,277,000.00 115,277,000.00 115,277,000.00 115,025,074.00
Diluted Share Outstanding 46,056,971.00 84,140,328.00 115,277,000.00 115,277,000.00 115,277,000.00 115,277,000.00 115,025,074.00
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation